Referral Line 800-216-5556 | Text Size: View larger font-size View regular font-size

REACT Clinical Trial Lung Cancer Detection Study

Last Updated 7/22/2011 3:31:45 PM

REACT Clinical Trial - A Case-Finding Trial Utilizing A Risk Stratification Protocol Involving A Genetic Susceptibility Test and Computed Tomography Screening for Identifying Lung Cancer Prevalence In Current or Prior Smokers


El Camino Hospital is offering a research study that includes a genetic test linked with other risk factors which could determine the likelihood of having lung cancer. Participants who are current smokers will receive smoking cessation counseling. All participants will undergo a low dose (CT) computed tomography image of the chest.

Basic Eligibility Criteria:

  • Age 50 or older
  • Current smoker or ex-smoker
  • Willing to participate in smoking cessation counseling if actively smoking
  • Have no symptoms or history of lung cancer
  • Previous cancer ok if no evidence of disease for > 5 years (current non-melanoma skin cancer or carcinoma in situ of the cervix ok)
  • Have smoked the equivalent of 20 cigarettes per day for 20 years
  • Are able to receive CT scans
  • Are not pregnant
  • Are able to swallow pills

Contact Information
For more information please call 650-988-7623.


REACT Information Handout

Image of Patient Flyer for React Clinical Trial - download, print and give to your patients.

Download this PDF flier for trial information

Video: ABC 7 TV on
REACT Lung Cancer Trial

Study Uses CT Scans to Find Lung Cancer (ABC 7 TV)

A clinical trial underway at El Camino Hospital combines genetic (DNA) screening and computed tomography (CT) scans of patients with a higher risk of lung cancer. Watch this video, produced by ABC-7 TV, about the REACT clinical trial.